New 独立行政法人 医薬品医療機器総合機構 · 2015. 5. 29. · ti/2 (h) 9.64b©...
Home
/
Documents
Post on 13-Oct-2020
0 views
0 download
Preview:
Click to see full reader
Report this document
SHARE
transcript
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Top related
shakai-senmon-i.umin.jpshakai-senmon-i.umin.jp/wordpress/wp-content/uploads/iryokikan_1… · Web view社会医学系専門医研修モデルプログラム （医療機関用）
Documents
E-labeling - 医薬品医療機器総合機構E-labeling Current status and Future Junko Sato, PhD Pharmaceuticals Medical Devices Agency (PMDA) 7th stJoint Conference of Taiwan and
Documents
Specifications - 医薬品医療機器総合機構 · degradation products that may have deleterious effect on the quality and safety: 1) prove that the substance is not present in
Documents
Q1A(R2) - 医薬品医療機器総合機構Q1A(R2) Document History First Codification History Date New Codification November 2005 Q1 Approval by the Steering Committee under Step
Documents
Danazol - 医薬品医療機器総合機構The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
Documents
Report on the Deliberation Results - 医薬品医療機器総合機構 · 2020. 8. 18. · This English translation of this Japanese review report is intended to serve as reference
Documents
Data Quality - 医薬品医療機器総合機構 · Evaluation and Data Reliability. It is stipulated in Pharmaceutical Affairs Act that examination of Efficacy and Safety of the
Documents
CM Research Outcomes - 医薬品医療機器総合機構IFPAC 2018 16 Why? Pharmaceuticals and Medical Devices Agency (PMDA) Process Validation (4) Change of the maximum batch size
Documents
Review Report - 医薬品医療機器総合機構 · Review Report February 6, 2009 . ... coronary artery and a delivery system used to deliver the stent. The surface of the stent
Documents
ThaiFDA - 医薬品医療機器総合機構ThaiFDA ThaiFDA-3 Sep. 2015 Celebrating MHLW/PMDA New International Strategic Plans Boonchai SOMBOONSOOK, M.D., M.T.H. Secretary-General
Documents
Age/ - 医薬品医療機器総合機構...Renal and urinary disorders/ Stress urinary incontinence/ STRESSINCONTINENCE (->TVT.O PROCEDURE TRANSVAGINAL TAPE 13JUL2006/602 20OCT2006/701
Documents
Regulatory Perspective on ICH - 医薬品医療機器総合機構6 1. Eligibility for a Regulatory Member –Implementation of Q1, Q7, E6 (Tier 1) 2. Implementation of ICH GLs (Rules
Documents
Labetalol Hydrochloride - 医薬品医療機器総合機構tion test, or the Content uniformity test according to the fol-lowing method: it meets the requirement. To 1 tablet of Labetalol
Documents
HOSPEX JAPAN 2015 「医工連携による医療機器開発ワーク … · 参入セミナー・ 交流会 ー育成講座 医療機器開発 コーディネータ 医療機器開発
Documents
Review Report - 医薬品医療機器総合機構 · Review Report August 6, 2007 Pharmaceuticals and Medical Devices Agency The results of a regulatory review conducted by the Pharmaceuticals
Documents
Lenvima Capsules 4 mg - 医薬品医療機器総合機構Brand Name Lenvima Capsules 4 mg Non-proprietary name Lenvatinib Mesilate Applicant Eisai Co., Ltd. Date of Application June
Documents
THE 10-YR EXPERIENCE - 医薬品医療機器総合機構10% 10% 7% 4% 3% 3% 3% 3% 3% 4% 27% Oncology Clinical Pharmacology Gastroenterology/ Hepatology Cardiology Neurology Respiratory
Documents
WORKSHOP - 医薬品医療機器総合機構ICH E8(R1) 「臨床試験の一般指針」 改訂の概要 医薬品医療機器総合機構 安藤友紀 2019.7.25 WORKSHOP ガイドラインの目次（抄）
Documents
医療機器の広告規制について...ITEM2019 展示説明会 2018/11/05 JIRA 法規安全部会 医療機器の広告規制について 1. 医療機器の広告規制 2. 未承認医療機器の展示会等への出展について
Documents
ICH HARMONISED GUIDELINE - 医薬品医療機器総合機構 · GUIDELINE FOR ELEMENTAL IMPURITIES ICH Harmonised Guideline Having reached Step 4 of the ICH Process at the ICH Steering
Documents